ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS ESCI Q3Scopus Q3SCImago #12,346Hybrid

Drug Research

Identifier (ISSN):2194-9379(Print)/2194-9387(Online)
•
Publisher:Thieme
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)
2.4↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS ESCIJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Drug Research

WoS Q3
12342.220231.720242.120252.42026
Annual Impact Factor Metric
Current (2026):2.4
Scopus SJR & RankScopus Q3
0.479
#12,346

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
76

76 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate5.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
50articles/year
1.52% Gold OA•78.13% Original Research

Aims & Scope

Drug Research (formerly Arzneimittelforschung) is an international peer-reviewed journal with expedited processing times presenting the very latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Articles and experimental data from across the field of drug research address not only the issue of drug discovery, but also the mathematical and statistical methods for evaluating results from industrial investigations and clinical trials. Publishing twelve times a year, Drug Research includes original research articles as well as reviews, commentaries and short communications in the following areas: analytics applied to clinical trials chemistry and biochemistry clinical and experimental pharmacology drug interactions efficacy testing pharmacodynamics pharmacokinetics teratology toxicology.

Topics Covered (Recognized by AI)
MedicineBiologyChemistryInternal MedicineBiochemistryPharmacologyGeneticsOrganic ChemistryEndocrinologyPsychologyPhysicsPathologyBioinformaticsPsychiatry
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRESCI2026

PHARMACOLOGY & PHARMACY

Q3
Rank215/356
IndexESCI
JCIESCI2026

PHARMACOLOGY & PHARMACY

Q4
Rank275/356
IndexESCI

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF2.4
Articles / Year22
Total Citations15
2025
IF2.1
Articles / Year45
Total Citations180
2024
IF1.7
Articles / Year58
Total Citations195
2023
IF2.2
Articles / Year57
Total Citations358
2022
IF—
Articles / Year75
Total Citations515

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #12,346Scopus Q3SCImago Profile
Scopus Coverage:1972, 2013-2026
Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q3
0.479

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3
Citations / Doc (2 years)
2.28

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,805 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations431
3-Year Documents169
Citable Documents169

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3
Medicine (miscellaneous)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Research (ISSN: 2194-9379) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Thieme in Germany. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.479 (Q3), an H-index of 76.

The journal enforces rigorous peer evaluation with an annual output of approximately 50 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,805 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Thieme
Publication Language
English
Frequency
Periodic
Indexing & Databases
ESCIScopusPubMed

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 43d19f9e-cf19-4a8f-8a90-c675e6e4b1d0
Database Updated: 2026-09-28